Combination simvastatin/ezetimib lowers cardiovascular risk in patients with chronic kidney disease

Abstract

SHARP study - The combination simvastatin and ezetimib reduces the cardiovascular risk of patients with chronic kidney disease.

Keywords

• Suimvastatin
• ezetimib
• cardiovascular risk
• chronic renal disease
• cholesterol